ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"

By ecancer FEATURING Jennifer Knox

82 views

June 20, 2024

0 Comments

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

2024 ASCO® Annual Meeting Insights Hub: GI Videos

10:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EA2174 Study - Peri-Operative Nivo & …

Feat. M. Gibson

08:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Atezo + Bev as 1L Systemic Therapy for aH…

Feat. M. Storandt

09:25

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…

Feat. N. Uboha, K. Spencer, M. Cecchini

View All

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. L. Zheng

27:37

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini

12:50

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…

Feat. E. Dotan

08:34

Yale Cancer Center

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Feat. J. Lacy

23:58

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta

20:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron

31:40

Horizon CME

Updates in Perioperative Therapy of Pancreatic Cancer

Feat. P. Philip

07:42

Integrity Continuing Education

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. W. Burns

03:50

UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg

12:08

Yale Cancer Center

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Feat. J. Lacy

08:08

Integrity Continuing Education

Updates in Nonmetastatic Upper-GI Adenocarcinoma

Feat. J. Hernandez

07:53

Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin

39:04

2023 Johns Hopkins Updates in Gastrointestinal Cancers

Localized Pancreatic Cancer Controversial Cases: Panel Discussion

Feat. M. Katz, A. De Jesus-Acosta, N. Zaidi, J. He, A. Narang, T. Bekaii-Saab

10:53

Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy

25:56

OncoAlert

Year in Review: Pancreatic Cancers

Feat. M. Lewis

30:55

2023 Johns Hopkins Updates in Gastrointestinal Cancers

Medical Oncology Updates in Pancreas Cancer

Feat. T. Bekaii-Saab

06:28

Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

22:10

Yale Cancer Center

Pancreatic Cancer Updates From Yale Cancer Center

Feat. J. Lacy

17:05

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…

Feat. A. Ohba

18:35

Rachna Shroff

Login

Login

Join VuMedi

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"

2024 ASCO® Annual Meeting Insights Hub: GI Videos

Related Content